Amylyx Pharmaceuticals (AMLX) Revenue (2021 - 2024)
Amylyx Pharmaceuticals' Revenue was -$636,000 in Q4 2024, compared with $108.45 million a year earlier.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Revenue (2021 - 2024) Analysis & Trends
For FY2024, Revenue at Amylyx Pharmaceuticals came in at $87.4 million, down 77.0% from FY2023.
- Revenue shows a three-year compound annual growth rate of 574.4% (FY2021 to FY2024).
- In earlier years, Revenue was $380.79 million in FY2023, $22.23 million in FY2022 and $285,000 in FY2021.
- The Q4 2024 figure marks the lowest quarterly Revenue in data going back to Q3 2021.
- Compared with a year earlier, Revenue was higher in two of the last four quarters, with growth averaging 55.3%.
- Per Business Quant data, AMLX's Revenue in the three quarters before Q4 2024 was $416,000 (Q3 2024), $1.02 million (Q2 2024) and $88.64 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -636,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 88.64 Mn |
| Dec 31, 2023 | 108.45 Mn |
| Sep 30, 2023 | 102.69 Mn |
| Jun 30, 2023 | 98.22 Mn |
| Mar 31, 2023 | 71.43 Mn |
| Dec 31, 2022 | 21.89 Mn |
| Sep 30, 2022 | 345,000.00 |
| Sep 30, 2021 | 285,000.00 |
API Access
Amylyx Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();